Objective To investigate the risk factors for non-anastomotic biliary stricture (NABS) following liver transplantation.Methods A retrospective analysis was performed on 175 patients who underwent liver transplantation from January 2004 to December 2010 to analyze the risk factors for NABS, which included sex, age, primary disease, blood type, T-tube placement, acute rejection, biliary tract infection, cytomegalovirus infection, Child-Pugh score, cold ischemia time, warm ischemia time, duration of anhepatic phase, and mean hepatic artery blood flow within one week after operation.These patients were divided into early group, who underwent operation from January 2004 to December 2006, and late group, who underwent operation from January 2007 to December 2010;each group was further divided into two subgroups according to whether they developed NABS.The risk factors for NABS were determined by univariate and multivariate logistic regression analyses.Results The univariate logistic regression analysis showed that the risk factors for NABS were biliary tract infection, T-tube placement, and acute rejection in the early group (P<0.05) and that acute rejection was the risk factor in the late group (P=0.003) .The multivariate logistic regression analysis showed that acute rejection was significantly associated with NABS in the early group (P=0.014) .Conclusion The risk factors for NABS following liver transplantation from January 2004 to December 2006;biliary tract infection and T-tube placement could be prevented by perioperative interventions, thus reducing the incidence of NABS.The incidence of acute rejection was reduced from January 2007 to December 2010, but it was still significantly associated with NABS.
[1]Patkowski W, Nyckowski P, Zieniewicz K, et al.Biliary tract com-plications following liver transplantation[J].Transplant Proc, 2003, 35 (2) :2316-2317.
|
[2]Desphande RR, Rela M, Girland R, et al.Long-term outcome ofliver retransplantation in children[J].Transplantation, 2002, 74 (8) :1124-1130.
|
[3]Scatton O, Meunier B, Cherqui D, et al.Randomized trial of choledo-choledochostomy with or without a T tube in orthotopic liver transplanta-tion[J].Ann Surg, 2001, 233 (3) :432-437.
|
[4]Vallera RA, Cotton PB, Clavien PA.Biliary reconstruction for livertransplantation and management of biliary complications:overviewand survey of current practices in the United States[J].LiverTranspl Surg, 1995, 1 (3) :143-152.
|
[5]Steinhoff G, Behrend M, Schrader B, et al.Intercellular immuneadhesion molecules in human liver transplants:overview on expres-sion patterns of leukocyte receptor and ligand molecules[J].Hepa-tology, 1993, 18 (2) :440-453.
|
[6]Zhang RL, Lu LG.Current research on the biliary tract diseases[J].J Clin Hepatol, 2011, 27 (9) :903-905, 908. (in Chi-nese) 张汝玲, 陆伦根.胆道疾病的研究现状[J].临床肝胆病杂志, 2011, 27 (9) :903-905, 908.
|
[7]Batts KP.Ischemic cholangitis[J].Mayo Clin Proc, 1998, 73 (4) :380-385.
|
[8]Huo SJ, Fan QS.Blood supply for eatra-hepatic puck and its clin-ical significance[J].Anatony and Clinics, 2004, 9 (2) :76-77. (in Chinese) 霍胜军, 范松青.肝外胆管的动脉血供及其临床意义[J].解剖与临床, 2004, 9 (2) :76-77.
|
[9]Colle I, Van Vlierberghe H, Troisi R, et al.Transplanted liver:consequences of denervation for liver function[J].Anant Rec ADiscov Mol Cell Evol Biol, 2004, 280 (1) :924-931.
|
[10]Neuhuber WL, Tiegs G.Innervation of immune cell:evidence for neu-roimmunomodulation in the liver[J].Anant Rec A Discov Mol CellEvol Biol, 2004, 280 (1) :884-892.
|
[11]Galloway G, Giuliani MJ, Burns DK, et al.Neuropathy associated withhyperoxaluria:improvement after combined renal and liver transplanta-tion[J].Brain Pathol, 1998, 8 (2) :247-251.
|